Registration confirmation

Thank you for registering for the PHAGO 2nd General Assembly Meeting in Paris, France!

 

We have reserved a contingent of 60 rooms for €90,- (incl. VAT) per person per night (single occupancy including breakfast) at the Hôtel Ibis Paris Porte d'Italie, which is located 15min walk from the meeting site.

 

Cancellation is free until 29th September after which charges do apply. For cancellations less than 7 days before the meeting the full amount will be charged.

 

Early check-in is available at a surcharge of €20,-. Alternatively, luggage can be stored at the Sanofi site.

 

Please arrange your own accommodation by sending an email to Ms Lucie Ginfray, detailing the nights you want to reserve and using the following booking code: 991122. Please provide your credit card information in the email.

 

There is limited capacity at the Hôtel Ibis Paris Porte d'Italie and we strongly recommend to make your booking before the 28th July 2017!
After this date, room availability cannot be guaranteed.

 

Partner will have to cover the costs for their travel and accommodation from their own budget.

 

On the days of the meeting, you will have to enter the Sanofi site through the entrance at 80 Avenue Raspail and show a valid ID. People not registered for the meeting will be unable to enter the site. Please note that your bags will be searched as part of the security procedure. Should you be unable to attend at short notice, please contact us.

 

We are looking forward to welcoming you to Paris!

Home
Menu
Top
 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.

Social Media

PHAGO by Twitter PHAGO by LinkedIn

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.